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Photoacoustic (PA) tomography (PAT) is a novel imaging modality that combines the fine lateral 
resolution from optical imaging and the deep penetration from ultrasonic imaging, and provides 
rich optical-absorption–based images. PAT has been widely used in extracting structural and 
functional information from both ex vivo tissue samples to in vivo animals and humans with 
different length scales by imaging various endogenous and exogenous contrasts at the ultraviolet 
to infrared spectrum. For example, hemoglobin in red blood cells is of particular interest in PAT 
since it is one of the dominant absorbers in tissue at the visible wavelength. 
The main focus of this dissertation is to develop high-speed PA microscopy (PAM) technologies. 
Novel optical scanning, ultrasonic detection, and laser source techniques are introduced in this 
dissertation to advance the performance of PAM systems. These upgrades open up new avenues 
for PAM to be applicable to address important biomedical challenges and enable fundamental 
physiological studies. 
First, we investigated the feasibility of applying high-speed PAM to the detection and imaging of 
circulating tumor cells (CTCs) in melanoma models, which can provide valuable information 
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about a tumor’s metastasis potentials. We probed the melanoma CTCs at the near-infrared 
wavelength of 1064 nm, where the melanosomes absorb more strongly than hemoglobin. Our high-
speed PA flow cytography system successfully imaged melanoma CTCs in travelling trunk 
vessels. We also developed a concurrent laser therapy device, hardware-triggered by the CTC 
signal, to photothermally lyse the CTC on the spot in an effort to inhibit metastasis. 
Next, we addressed the detection sensitivity issue in the previous study. We employed the 
stimulated Raman scattering (SRS) effect to construct a high-repetition-rate Raman laser at 658 
nm, where the contrast between a melanoma CTC and the blood background is near the highest. 
Our upgraded PA flow cytography successfully captured sequential images of CTCs in mouse 
melanoma xenograft model, with a significantly improved contrast-to-noise ratio compared to our 
previous results. This technology is readily translatable to the clinics to extract the information of 
a tumor’s metastasis risks. 
We extended the Raman laser technology to the field of brain functional studies. We developed a 
MEMS (micro-electromechanical systems) scanner for fast optical scanning, and incorporated it 
to a dual-wavelength functional PAM (fPAM) for high-speed imaging of cerebral hemodynamics 
in mouse. This fPAM system successfully imaged transient changes in blood oxygenation at 
cerebral micro-vessels in response to brief somatic stimulations. This fPAM technology is a 
powerful tool for neurological studies. 
Finally, we explored some approaches of reducing the size the PAM imaging head in an effort to 
translate our work to the field of wearable biometric monitors. To miniaturize the ultrasonic 
detection device, we fabricated a thin-film optically transparent piezoelectric detector for 
detecting PA waves. This technology could enable longitudinal studies on free-moving animals 
through a wearable version of PAM.
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Chapter 1: Introduction 
This chapter introduces the concept, implementation, and applications of photoacoustic 
tomography (PAT). In section 1.1, the physical mechanism of PAT is reviewed, followed by an 
introduction to several representative implementations of PAT. In section 1.2, an outline of this 
dissertation is given. 
1.1 Introduction to Photoacoustic Tomography 
PAT is an imaging technology based on the photoacoustic (PA) effect1, in which the short-pulsed 
laser energy absorbed by biomolecules is first converted to heat through non-radiative relaxation2. 
Subsequently, the spatially confined heat is converted to a pressure rise via thermoelastic 
expansion, and the initial pressure rise propagates in tissue as an ultrasonic wave—PA wave2. This 
PA wave is usually detected by one or a matrix of ultrasonic transducers to reconstruct the mapping 
of the optical absorption in tissue3. PAT is also a highly scalable imaging modality, capable of 
imaging objects of a broad range of length scales, from organelles to organs, with respective 
appropriate resolutions4. 
Photoacoustic microscopy (PAM) is the microscopic implementation of PAT5. In a standard PAM 
setup, a pulsed laser beam is focused onto the tissue. And a high-frequency ultrasonic transducer 
is placed co-axially with the laser beam to detect the PA waves with high sensitivity6. The acquired 
PA signal, A-line, is temporally resolved to form a one-dimensional (1D) image along the axial 
direction (depth-resolved image). A three-dimensional (3D) image is acquired by raster scanning 
(C-scan) the probing laser or the imaging object7, 8. 
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1.2 Dissertation outline 
This dissertation is focused on the development and applications of PAM. It is arranged in the 
following structure. 
Chapter 2 describes the development of a PAM technology for high-speed flow cytography of 
circulating melanoma cells in vivo, which exploits the high optical absorption contrast between 
melanoma cells and the blood background. We also developed a concurrent on-demand laser 
therapy device that works in a selective identify-then-locally-administer manner, in an effort to 
inhibit cancer metastasis. 
Based on the previous work, Chapter 3 addresses some technological limitations of Chapter 2 by 
improving the detection sensitivity of PAM. We explore a wavelength conversion technique, 
stimulated Raman scattering, to probe the circulating melanoma cells at a laser wavelength that 
gives higher contrast. It achieves a detection sensitivity at least 4 times higher than that in Chapter 
2, and successfully imaged circulating melanoma cells in a tumor xenograft model. 
Chapter 4 extends the work in Chapter 3. It introduces a dual-wavelength high-speed function 
PAM (fPAM) based on a Raman laser. Both the scanning and detection devices are significantly 
improved with novel techniques. We applied this fPAM in studies of mouse brain activity in 
response to somatic stimulations, and resolved transient hemodynamic changes on a single micro-
vessel scale. 
Chapter 5 extends the scope of Chapter 4. It explores some approaches towards wearable PAM. A 
lithium niobate-based optically transparent ultrasonic transducer is developed to minimize the 
ultrasonic detection device. Its application in PAM is demonstrated with a phantom and small 
animal experiment. 
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Chapter 6 summarizes all the works in this dissertation, and outlines some prospective studies for 
each chapter.  
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Chapter 2: In vivo label-free photoacoustic 
flow cytography and on-the-spot laser killing 
of single circulating melanoma cell 
This chapter introduces a hybrid PAM and laser therapy system for the application of flow 
cytography and destruction of circulating tumor cells (CTCs). Here we focused on the skin cancer 
melanoma. Exploiting the exquisite intrinsic optical absorption contrast of melanoma CTCs in the 
blood background, we developed dual-wavelength photoacoustic flow cytography coupled with a 
nanosecond-pulsed melanoma-specific laser therapy device. We have successfully achieved in 
vivo label-free imaging of rare single circulating melanoma cells in both arteries and veins of mice. 
Further, the photoacoustic signal from a circulating melanoma cell immediately hardware-triggers 
a lethal pinpoint laser irradiation to kill it on the spot in a thermally confined manner without 
collateral damage. A pseudo-therapy study including both in vivo and in vitro experiments 
demonstrated the performance and the potential clinical application of our technology, which can 
facilitate early treatment of metastasis in a dialysis manner by clearing circulating tumor cells from 
vasculature. The work in this chapter has been published in Scientific Reports9. 
2.1 Background 
As many as 90% of cancer-related deaths are attributed to metastases, the process of cancer cells 
spreading from a primary site to surrounding and distant sites to form new tumor colonies10-13. 
Most metastasis cases take the route of hematogenous dissemination of CTCs, including steps such 
as a tumor cell with invasive phenotypes intravasating local blood vessels, surviving in blood 
circulation, extravasating the vessel wall14. Here we focused on the deadliest type of skin cancer, 
melanoma. In United States, it has more than 87,000 new diagnoses and 10,000 deaths each year15. 
Melanoma has a high tendency to metastasize even at an early stage, after which the 5-year survival 
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rate decreases from 98.5% to less than 20%15. The presence and concentration of CTCs are closely 
correlated with tumor progression, metastases, and survival rates in patients16. Therefore, efficient 
detection and early eradication of melanoma CTCs are vital for cancer diagnosis and improving 
patient prognosis. 
Clinical ex vivo CTC detection with high sensitivity remains a challenge since it heavily depends 
on both small-volume sampling of blood and labeling of biomarkers on the cell membrane17, 18. 
Extensive in vivo CTC detection studies employing fluorescence probes or multiplex nanoparticles 
have achieved promising results17, 19-21, but the biosafety and labeling efficiency remain critical 
concerns, which limits their clinical translation. In the biological tissue background, melanoma 
cells have a high melanosome expression, providing a striking endogenous absorption contrast in 
the red to near-infrared (NIR) spectrum22, 23. Hence, PAT, having the highest possible sensitivity 
to absorption contrast, is an excellent technology for label-free imaging of melanoma cells. In 
2009, Galanzha et al. reported label-free detection of melanoma CTCs in vivo using PA cytometry, 
in which a pulsed laser was focused across a blood vessel and an ultrasonic transducer collected 
PA signals from a large voxel24. This design enables detection of melanoma CTCs in situ, but it 
lacks imaging capabilities. A recently developed optical-resolution PA imaging technique has 
acquired images of single CTCs in vivo25. However, its non-optic-acoustic-confocal configuration 
and low CTC-to-background contrast limit the applications to capillaries and require complicated 
pattern recognition to identify CTCs. High-contrast flow cytography that can reliably distinguish 
CTCs in real-time is needed for on-the-fly targeted CTC therapies. 
Traditional clinical therapies for tumor metastasis are still palliative, with many drugs not reaching 
metastasis sites26. Novel therapies based on particular metastasis features, such as angiogenesis, 
lymphangiogenesis, specific signal pathways and biomarkers, have reported good clinical 
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outcome26, 27, but they have less efficacy on initial micro-metastasis sites and typically produce 
adverse side effects28, 29. Taking another approach, therapies directly targeting CTCs can reduce 
tumor metastasis potentials and may even prevent metastasis from occurring if administered in 
early tumor stages13. Nanosecond-pulsed lasers at 680–1064 nm wavelengths have long enabled 
physicians to treat melanocytic skin lesions with a high degree of selectivity and a low risk of 
postoperative complications30, 31. For laser pulses shorter than the thermal relaxation time, radiant 
energy is largely confined in the absorber, which can achieve efficient energy delivery and 
selective photothermolysis of the absorbing cells32. When a nanosecond laser pulse with sufficient 
energy irradiates a melanoma CTC, the melanosomes inside are heated beyond the threshold 
temperature for explosive vaporization, photomechanically killing the CTC without damaging any 
adjacent tissue components32, 33. 
Here we report high-resolution CTC imaging, using our new dual-wavelength PA flow cytography 
technology, in combination with real-time CTC destruction at the single-cell scale by pinpoint 
nanosecond-pulsed lethal irradiation from a therapy laser. We obtained images of single CTCs 
flowing in both arteries and veins on the fly, and performed real-time CTC destruction in vivo in 
small animals. The performance of this system was demonstrated by a study mimicking treatment 
of melanoma metastasis. 
2.2 Methods 
2.2.1 Dual-wavelength PA flow cytography 
To induce PA signals, we employed a high-repetition-rate picosecond laser (APL-4000-1064, 
Attodyne, Inc.; maximum pulse repetition rate: 500 kHz) to provide 6-ps laser pulses at 1064 nm 
and 532 nm wavelengths. After traveling a 25-meter delay line, the 532 nm laser beam was 
combined with the 1064 nm laser beam through a longpass dichroic mirror. Melanosome absorbs 
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similarly to Hb at 532 nm, but >10 times more strongly than Hb at 1064 nm, which provides a high 
CTC contrast against the RBC background. The combined laser beams were focused by a focusing 
lens, reflected by an optical-acoustic combiner (OAC), and directed to the target by a water-
immersible MEMS (micro-electro-mechanical system) scanner for 1D fast scanning. The target 
was mounted on a stepper-motor-driven translational stage to facilitate orthogonal slow axis 
scanning. The OAC comprised of an aluminum-coated prism and an uncoated prism, and the thin 
aluminum coating on the first prism reflected light but transmitted sound. A correction lens was 
attached to the top surface of the OAC to correct the optical aberration due to the prisms. Excited 
PA waves were also reflected by this MEMS mirror, collected by an acoustic lens, transmitted 
through the OAC, and detected by an ultrasonic transducer (V214-BB-RM, Olympus-NDT, Inc.). 
Since the 532 nm laser pulse traveled through the ~80-ns delay line, the PA wave induced by the 
532 nm laser pulse arrived ~80 ns later than that by the 1064 nm laser pulse (Figure 2.1a). PA 
signals were then amplified by two radio-frequency amplifiers (ZX60-3018G-S+ and ZFL-
500LN+, Mini-circuits, Inc.) and acquired by a high-speed digitizer (ATS9350, Alazar Tech, Inc.). 
By steering both the optical and acoustic axes simultaneously, the system maintained confocal 
alignment over the entire FOV, providing high detection sensitivity. This flow cytography was 
capable of volumetric (3D) imaging at 10 Hz over a FOV of 3 × 0.25 mm2 at a depth up to ~0.7 
mm, with a 3 µm lateral resolution for the 532 nm flow cytography images, 7 µm for the 1064 nm 
flow cytography images, and ~26 µm axial (depth) resolution for both. The length and width of 
the FOV can be tuned by varying the driving voltage of the MEMS mirror and by adjusting the 
scanning range of the stepper motor, respectively. It is also possible to achieve a higher frame rate 
at the expense of a larger scanning step size, as in Figure 2.3, or of a shorter range for the stepper 
motor. 
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Figure 2.1 CTC imaging and destruction by dual-wavelength PA flow cytography combined with laser therapy. 
(a) Schematic of selected components of the experimental system. DM, dichroic mirror; MEMS, micro-electro-
mechanical-system scanning mirror; OAC, optical-acoustic combiner; PBS, polarizing beamsplitter; UT, ultrasonic 
transducer. The 1064 nm and 532 nm imaging lasers are employed to image CTCs and vasculature, respectively. (b-
e) Scheme of real-time detection and laser killing of CTCs. The CTC detector compares the earlier 1064 nm laser-
induced CTC-specific PA signal against an optimized threshold level (purple dashed line in (b) and (c)) above the Hb 
signal, and thus can reliably distinguish CTCs and trigger the therapy laser (c). Within ~10 µs, the therapy laser is 
fired and focused to the detected CTC location to photomechanically kill the CTC (e). 
2.2.2 On-the-fly CTC detection 
PA signals were concurrently analyzed for melanoma CTC detection based on the melanosome-
specific 1064 nm absorption induced PA signals (Figure 2.2). The specially built CTC detector 
consisted of an ultrafast analog switch and a comparator (Figure 2.2). Based on the fixed 80-ns 
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time interval between the 1064 nm and 532 nm laser pulses, a time window signal controlled the 
analog switch as a gate to selectively transmit the earlier 1064 nm laser-induced PA signal. The 
comparator compared this gated PA signal with an optimized preset threshold voltage. A signal 
above the threshold indicated the presence of a melanoma CTC, and immediately triggered a 
high-pulse-energy therapy laser (INNOSLAB, EdgeWave, Inc.) to lethally irradiate the same 
CTC on the spot (Figure 2.1c-d). Following a successful CTC detection, the detector was 
disabled for 1 ms to prevent double triggering by the much-higher-amplitude therapy laser-
induced PA signal. 
 
Figure 2.2 Circuit diagram and performance of the lab-made CTC detector. (a) Circuit diagram. The time gate 
signal (TTL logic) controls an ultrafast analog switch (SN74LVC1G3157, Texas Instruments Inc.) as a gate. Based 
on the fixed 80-ns time interval between the 1064 nm and 532 nm laser pulses in the dual-wavelength flow cytography, 
the time gate signal is employed to selectively gate the PA signals, allowing only the earlier PA signal induced by the 
1064 nm laser pulse to pass through to the comparator. The voltage comparator (TLV3502, Texas Instruments Inc.; 
4.5 ns propagation time) compares the gated PA signal to distinguish CTCs from RBCs and other blood cells. Once 
the signal peak is above the optimized preset threshold voltage (80 mV), a trigger signal is generated for the therapy 
laser. The high-speed characteristics of the analog switch and comparator guarantee real-time CTC detection and 
therapy-laser triggering. (b) Time sequence plot of the PA signal, time gate control signal, gated PA signal, and output 
trigger. The time interval from the 1064 nm laser-induced PA signal from a CTC to the output trigger is ~30 ns. 
2.2.3 Real-time CTC destruction 
Melanoma CTCs were irradiated by a high-pulse-energy 1064 nm laser pulse (7 ns) that could 
mechanically destroy the CTCs by explosive vaporization of the melanosomes inside (Figure 
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2.1de)32-34. The thermal diffusion distance during 7-ns laser exposure is ~30 nm, which means the 
thermal damage is confined to melanosomes, ~500 nm in diameter32. The therapy laser beam was 
coaxially aligned with the imaging laser beams by a polarizing beamsplitter and focused onto the 
CTC location. In order to maximize combining efficiency, a half-wave plate was used to adjust 
the polarization of the therapy laser beam. We optimized the focal spot size of the therapy laser 
based on the scanning speed of the MEMS mirror, the signal propagation and processing time, the 
CTC flow speed, and the therapy laser’s trigger-to-emission delay. The maximum scanning speed 
of the laser focal spot on the target was ~1 m/s. The acoustic flight time from the absorber to the 
ultrasonic transducer was ~10 µs, while the signal processing time in the CTC detector circuits 
was ~30 ns and the trigger-delay time of the therapy laser was ~300 ns. Based on the blood flow 
speed, the CTC movement in blood vessel during the ~10 µs response time was negligible. In 
conclusion, the center of the therapy laser’s focal spot could be ~10 µm (1 m/s × 10 µs) away from 
the original imaged CTC location. Therefore, the focal spot of the therapy laser, with 25 J/cm2 
fluence, was adjusted to be 50 µm in diameter to ensure coverage of the entire CTC with a 
sufficient local radiant intensity. 
2.2.4 Experimental animals 
Adult female ND4 Swiss Webster mice (Hsd: ND4, Envigo, Inc.; 20-25 g, 10-12 weeks old) were 
used for the in vivo CTC imaging and laser killing experiment. The laboratory animal protocols 
were approved by the Animal Studies Committee of Washington University in St. Louis. Three 
days before the experiment, cannulation was performed to safely insert a catheter into the jugular 
vein or carotid artery of the mouse, and the hair on the mouse ear was removed with human hair-
removing lotion. During the experiment, the mouse was maintained under anesthesia with 1.5% 
vaporized isoflurane, and taped to a lab-made animal holder, which was mounted on the stepper-
11 
 
motor-driven translation stage. Ultrasound gel was then applied to the imaging area to retain 
moisture and couple acoustic signals. A water tank filled with deionized water was then placed on 
top of the mouse ear. The membrane at the bottom of the water tank was in gentle contact with the 
ultrasound gel. During imaging, a 0.1-ml suspension containing ~106 B16F10 melanoma cells was 
injected through the cannulation catheter. The cells were cultured in DMEM supplemented with 
10% fetal bovine serum at 37 ºC in a humidified atmosphere with 5% CO2. 
Female athymic nude mice (Hsd:Athymic Nude-Foxn1, Envigo, Inc.; 12-15 g, 3-4 weeks old) were 
used for the pseudo-therapy study. The laboratory animal protocols were approved by the Animal 
Studies Committee of Washington University in St. Louis. Before the study, the mice were 
randomly assigned into either the therapy group or the control group. In one experiment, a mixture 
was first prepared by diffusing cultured B16F10 melanoma cells into bovine blood (Defibrinated 
Bovine Blood, Quad Five, Inc.). Next, this mixture was pumped in a translucent silicone tube (300 
µm inner diameter and 640 µm outer diameter)—mimicking a blood vessel—through our system 
with the therapy laser turned on. The flow rate was set at ~80µL/hr, with ~20 CTCs passing 
through the system every second. Afterwards, the cell mixture was reduced in volume by 
centrifugation to make a 50 µL dose (containing ~105 cells) that was subcutaneously inoculated 
into the dorsal area of a nude mouse in the therapy group. Then, another vial of mixture was 
acquired in a similar manner but with the therapy laser turned off, and a 50 µL dose of this imaged 
(but not treated) mixture was inoculated into a nude mouse in the control group. Afterwards, all 
the mice were imaged by acoustic resolution PAM to detect tumor formation and to measure the 
volume of flat tumors, and raised tumors were measured using a caliper35. Mice were euthanized 
when the tumor dimension exceeded 2 cm or the tumor began to ulcerate. 
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2.3 Results 
2.3.1 Imaging results 
To exploit the NIR absorption contrast between melanosome and hemoglobin (Hb) in red blood 
cells (RBCs), and to image CTCs on the fly, we developed a fast scanning PA flow cytography 
system for high-speed imaging at both 532 nm and 1064 nm wavelengths with single-cell 
resolution coupled with real-time selective CTC destruction by nanosecond-pulsed NIR laser-
induced photothermolysis (Figure 2.1). The therapy laser beam is coaxially aligned with the two 
imaging laser beams, and is triggered, using real-time hardware, immediately after flow 
cytography detects a CTC (Figure 2.1b-e, Figure 2.2). We first validated the system’s ability to 
image single CTCs with the therapy laser turned off. To simulate CTCs, ~106 cultured B16F10 
melanoma cells were administrated into the mouse’s blood circulation system through jugular vein 
cannulation, and a portion of these cells survived in circulation as CTCs. A 1.2 × 0.3 mm2 area of 
an artery-vein pair in the mouse ear was imaged by flow cytography at a 16.6 Hz volumetric (3D) 
rate. Figure 2.3 shows some snapshots of single CTCs flowing through the field of view (FOV) in 
the artery and the vein. As shown in Figure 2.3a, the vascular structure was imaged with high 
contrast by the 532 nm laser owing to the strong light absorption by Hb in RBCs at this wavelength. 
However, CTCs can hardly be distinguished from RBCs in these images, mainly due to the similar 
absorption coefficients for melanosome and Hb at 532 nm. In comparison, the 1064 nm laser pulse 
excitation of a CTC produced a PA signal with ~5 times greater amplitude than the background, 
while RBC signals were below the noise level. We performed control studies for 20 minutes before 
cell injection and recorded no PA signals of a similar amplitude level, which verified that the high-
amplitude 1064 nm laser-induced PA signals indeed originated only from CTC absorption. The 
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arterial and venous flow speeds of the CTC were calculated to be 0.33 mm/s and 0.20 mm/s, 
respectively, which are in general accordance with previously reported values. 
 
Figure 2.3 Snapshots showing single CTCs travelling in vasculature. (a) 532 nm laser-induced (Top), 1064 nm 
laser-induced (Middle), and fused (Bottom) flow cytography images. In the 1064 nm laser-induced image, the white 
arrow and yellow square indicate the detected CTC; the red and blue dashed lines delineate the artery and vein 
boundaries, respectively. (b) Three fused snapshots spanning ~1 s, showing a single CTC traveling in the artery. (c) 
Three fused snapshots spanning ~2 s, showing a single CTC traveling in the vein. The times labeled in (b) and (c) are 
relative to CTC injection. 
A CTC cluster flowing in an artery was also imaged in vivo in a carotid artery cell injection 
experiment (Figure 2.4). No return of this CTC cluster was observed, which indicated that it might 
have been clogged at a vascular branching point, seeding a secondary tumor. 
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Figure 2.4 Sequential flow cytography images of a CTC cluster flowing through an artery in a mouse ear. About 
106 cultured B16F10 cells were administered through carotid artery cannulation. Some of the cells were naturally 
bound together by cell adhesion as clusters. A 2.0 × 0.5 mm2 area of vasculature over a depth of ~150 µm in the mouse 
ear was imaged by flow cytography at a 5 Hz volumetric (3D) rate. As it flowed through the FOV, a CTC cluster in 
the artery was imaged in four successive frames. The size of the cluster was estimated to be 25-40 µm. Since the 
dynamics of CTC clusters may be turbulent inside the blood vessel and the scanning step size is ~5 µm, the PA signal 
of the CTC cluster fluctuated. 
2.3.2 Therapy results 
To investigate the radiant energy required to kill a CTC, we used a single-shot 1064 nm laser 
pulse to irradiate cultured B16F10 melanoma cells in vitro. Different areas of a monolayer of 
melanoma cells were irradiated with increasing levels of laser fluence, and then the cells were 
stained with trypan blue to test cell viability (Figure 2.5). The results indicated that a 1064 nm 
laser pulse with 8.8 J/cm2 fluence was sufficient to guarantee cell death. 
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Figure 2.5 Irradiation of melanoma cells in vitro. (a) B16 cells on glass slides were irradiated by increasing levels 
of laser fluence and stained with trypan blue to test cell viability. (b) Plot of cell death percentage versus laser fluence. 
Potential tissue damage by the therapy laser was also carefully investigated. A monolayer of RBCs 
was imaged by phase contrast microscopy before and after 30 J/cm2 laser irradiation (Figure 2.6). 
Comparison of the two images indicated no apparent change, with both showing donut-shaped 
morphology. 
 
Figure 2.6 Phase-contrast images of RBCs acquired before and after exposure to single-shot 1064 nm laser 
irradiation with 30 J/cm2 fluence. Close-ups of the same region (enclosed by the red rectangles) before and after 
exposure, placed at the bottom right corners of the two images, indicate no apparent morphological change. 
In addition, measuring the optical absorbance of the supernatant showed no RBC hemolysis in 
blood samples exposed to 30 J/cm2 laser irradiation (Figure 2.7). 
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Figure 2.7 RBC hemolysis study results. (a) Potential RBC hemolysis by an energetic 1064 nm laser was studied 
by irradiating flowing blood samples at a 30 J/cm2 fluence level. Bovine blood was washed three times with saline 
before the experiment, then it was pumped through a glass tube (100 µm inner diameter) at a 0.15 mm/s flow speed. 
Laser light (5 kHz repetition rate) was focused across the tube by a cylindrical lens with a 30 µm focal width. An 
inverted microscope was used to help position the tube in the focal zone of the lens. (b) The optical absorbance of the 
supernatants at 532 nm indicates no detectable hemolysis was caused by the therapy laser irradiation. For the two 
control groups, the therapy laser was turned off during pumping. Blood samples from the negative control and the 
study groups were diluted 20 times with saline, while that of the positive control group was diluted 20 times with pure 
water to induce total hemolysis. All blood samples are centrifuged at 3000 rpm for 10 min, and the supernatants 
(photos shown at the top right corner of each group) were extracted to measure their optical absorbance at 532 nm. 
Equation 𝑅 ൌ ሺ𝐴௦ െ 𝐴଴ሻ/𝐴ଵ଴଴ is used to calculate the hemolysis ratio R, where 𝐴௦ is the absorbance of the supernatant 
from the study group; 𝐴଴ and 𝐴ଵ଴଴ are that from blood samples with no hemolysis (negative control) and 100% 
hemolysis (positive control), respectively. 
Therapy experiments were conducted in a similar manner to the imaging experiments. Figure 2.8 
shows an event of single-CTC detection and real-time destruction. The CTC signal induced by the 
1064 nm laser pulse immediately hardware-triggered a therapy laser pulse to irradiate the detected 
CTC with a 50 µm focal diameter and a 25 J/cm2 fluence, above the lethal level. This lethal 
irradiation produced a PA signal with a much greater amplitude, ~14 times higher than the maximal 
imaging signal (Figure 2.8c), and its peak location indicated that the CTC was within the focal 
spot of the therapy laser. 
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Figure 2.8 In vivo detection and expected photothermal killing of a CTC. The CTC was first detected in the 1064 
nm laser-induced flow cytography image (a) and then lethally irradiated by a therapy laser pulse, also at 1064 nm, 
with a 50-µm focal diameter (b). In (b), The much-higher-amplitude PA signal induced by the therapy laser pulse is 
illustrated by the filled yellow circle. (c) Profile of the PA signals from the region across the CTC, indicated by the 
dashed cyan line in (a). The x axis, parallel with the imaging laser’s scanning direction (from right to left), was centered 
at the CTC location. In the 1064 nm imaging laser-induced signals (red solid line), the CTC signal (shown in detail 
by the inset) had a contrast-to-noise-ratio (CNR) of ~25. The therapy laser-induced PA signal’s peak location (dashed 
orange line) was only ~10 µm away from the detected CTC location, which indicated that the CTC position (white 
cross in (b)) was within the therapy laser’s focal spot (circle in (b)). 
This PA signal amplitude, measured in another experiment, was far higher than that of a regular 
blood vessel with the same irradiation (Figure 2.9). Therefore, we concluded that this PA signal 
mainly originated from light absorption by the CTC, and that this CTC was destroyed by the 
therapy laser irradiation. In total, four events of real-time expected photothermal killing of CTCs 
at different locations were recorded during 5 minutes in the experiment. Flow cytography 
confirmed no disturbance to blood flow during 30 min of observation after this experiment. In 
addition, there were no visible damages on the mouse ear. 
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Figure 2.9 Therapy laser-induced PA signals. Therapy laser-induced PA signals from a blood vessel containing a 
CTC within the laser’s focal spot (black), and that from the same blood vessel when it does not contain a CTC (red). 
Data are averaged over ten measurements; error bars show the standard deviations. 
We also conducted a pseudo-therapy study to evaluate the performance of the system and 
demonstrate the value of this therapy scheme. Experiments were designed to mimic treating 
melanoma metastasis by impeding CTC dissemination (Figure 2.10a). First, cultured B16F10 cells 
were mixed with bovine blood and pumped into a translucent silicone tube to simulate CTCs. Then 
this mixture was pumped through our system to specifically detect and kill the CTCs. For the 
control experiment, the therapy laser was turned off during the experiment, leaving the CTCs only 
imaged by our system. Next, the treated and untreated mixtures were subcutaneously inoculated 
into two groups of nude mice, respectively, simulating hematogenous metastases. 
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Figure 2.10 Scheme and results of the pseudo-therapy study. (a) The control experiment (bottom) was conducted 
after the therapy experiment (top) by simply switching off the therapy laser. The flow rate was set at ~80 µL/hr with 
~20 CTCs flowing through the system every second. (b) Only 1 out of 6 therapy experiments had a tumor detected at 
week 3, compared to 100% tumor formation by week 1 in the control group. (c) Representative photos of the mice 
after experiments. (Left) No tumor was detected around the inoculation site (blue arrow) in 30 days following a therapy 
experiment. (Right) A raised tumor (blue arrow) was observed 10 days after a control experiment. 
Afterwards, the area around each inoculation site was imaged every week by acoustic resolution 
(AR) PAM36, 37 at 750 nm wavelength, to monitor tumor formation (Figure 2.11). 
 
Figure 2.11 Tumor size measurement. (a) Photograph of a flat tumor (blue arrow) in the control group taken 5 days 
after experiment. (b) Three-dimensional AR-PAM image of this tumor. Its volume is calculated to be 2.01 mm3. 
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After 30 days, only one of the six therapy experiments resulted in a tumor formation, and that 
tumor had a significantly slower growth, in comparison to the rapid tumor formation and growth 
following every control experiment (Figure 2.10bc, Figure 2.12). This only tumor from the therapy 
experiment could be attributed to the fact that the therapy laser (1 kHz maximum repetition rate) 
missed some CTCs that were detected within 1 ms after the last therapy laser shot, which should 
not present a real problem since CTCs are rarer in vivo and the repetition rate of the therapy laser 
can be increased. The results indicated that our technique is capable of destroying CTCs with a 
high success rate, and that this therapy scheme is a promising way to impede metastasis for cancer 
therapy. 
 
Figure 2.12 Comparison of tumor growth in the pseudo-therapy study. No tumor was detected using AR-PAM 
from five out of six therapy experiments by week 5 (green dashed line), and the only other therapy experiment resulted 
with a tumor that had a significantly slower growth (red dashed line), compared with that of the control experiments 
(blue solid line). Tumor volume was measured by AR-PAM (for flat tumors) or estimated by the formula π/6 × L × 
W × H (for raised tumors), where L, W, and H represent length, width, and height, respectively. Asterisk: mouse 
euthanasia; error bar: standard deviation. 
2.4 Discussion 
We report both in vivo label-free imaging of melanoma CTCs using dual-wavelength PA flow 
cytography and on-the-spot pinpoint CTC destruction by nanosecond-pulsed NIR therapy laser 
irradiation. CTCs are important indicators of the severity of a tumor and the efficacy of tumor 
therapies, making their reliable detection clinically significant. Because some CTCs are cloaked 
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by platelets or coagulation factors, they are shielded from many CTC detection agents as well as 
from the immune system12, 18. However, our method does not suffer from this limitation because 
light can penetrate CTCs. This technique may be used clinically for non-invasive in vivo CTC 
assays without labeling. In addition, many details about the process of tumor metastasis through 
CTCs are still unclear, and this high-resolution real-time CTC imaging technique can enable in 
vivo studies of CTC dynamics, such as monitoring tumor cells shedding from a primary tumor, 
invading nearby blood vessels, circulating in the vasculature, and extravasating from vascular 
walls. 
Unlike therapeutics that use metastasis-specific features re-distribute the administered medication, 
the reported method works on a more selective “identify-then-locally-administer” basis. Because 
the radiant energy from the therapy laser is highly confined to the melanosomes within CTCs, 
other molecules in the CTCs, as well as adjacent RBCs, do not sustain damage. Moreover, our 
technology may have extra benefits in immunotherapy because it can help release viable tumor-
specific antigens from lysed CTCs into vasculature, which can stimulate immune attacks on 
remaining CTCs as well as metastases, enhancing treatment efficacy38. Drug resistance from CTCs 
is also not an issue in our study because the destruction mechanism is completely physical. 
Melanoma patients at all stages would potentially benefit from this technology if it were translated 
into the clinic successfully. For stages I and II, measuring CTC count could yield a more accurate 
diagnosis of a melanoma’s recurrence risks. For stage III, when there are CTCs in the bloodstream 
but no existing metastases, and stage IV, when there are CTCs in the bloodstream and existing 
metastases, the clearance of CTCs would potentially prevent metastasis. The immunoresponse 
induced by antigens released by lysed CTCs could potentially further treat any residual primary 
tumor as well as existing metastases. 
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In summary, using endogenous contrast, our system dynamically imaged rare single CTCs and 
CTC clusters with single-cell resolution in vivo and performed real-time pinpoint photothermolysis 
of CTCs. The pseudo-therapy experiment demonstrated that our method can effectively kill CTCs 
in vasculature. This technology works in a convenient reflection mode, and is translatable to 
clinics. It can serve as a bedside therapy device for cancer patients, which can improve their 
prognosis by early detection and destruction of CTCs. The technology can also be applied for 
studying fundamental mechanisms of tumor metastasis through CTC dissemination. 
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Chapter 3: High-sensitivity photoacoustic 
flow cytography of circulating melanoma 
cells enabled by a 1 MHz Raman laser 
Following the work in Chapter 2, this chapter continues the work on in vivo detection of CTCs. 
CTC is one of the key indicators of metastasis, which is responsible for the majority of cancer-
related mortalities. Detection and characterization of CTCs in vivo can provide valuable 
information for cancer patients’ diagnoses. Exploiting the intrinsic optical absorption contrast of 
melanin, we present a Raman-laser–based dual-wavelength high-speed photoacoustic (PA) flow 
cytography for imaging melanoma CTCs in vivo. Via the stimulated Raman scattering effect, a 
KGd(WO4)2 crystal works as a Raman shifter to convert 532 nm pump laser to 658 nm, at up to a 
1 MHz repetition rate. Since melanin absorbs more than 100 times more strongly than hemoglobin 
at this wavelength, PA flow cytography can easily detect rare melanoma CTCs in the blood 
background, quantify their contrast-to-noise ratio, and measure their flow speeds. In mouse 
melanoma xenograft models, we have sequentially imaged the flow of rare CTCs in vivo. This PA 
flow cytography holds great promise for both tumor metastasis studies and clinical disease 
monitoring. 
3.1 Background 
Metastasis, the spreading of cancer cells from a primary tumor to distant sites, accounts for up to 
90% of cancer-associated mortalities10-12. Most metastases involve the hematogenous 
dissemination of circulating tumor cells (CTCs)11, 39, involving steps including cancer cells 
acquiring an invasive phenotype via mutations, entering the local blood vessels by intravasation, 
surviving in the blood circulation, extravasating through the vessel wall, and colonizing a new 
tumor11, 21. In this complicated process, rare CTCs, acting as cancer seeds, are key indicators of a 
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tumor’s metastatic propensity13, 40. Thus, efficient detection and characterization of CTCs can 
provide critical information for cancer diagnosis and staging, and for assessing the efficacy of 
therapy41-44. 
Many recent studies employing various contrast mechanisms have enabled reliable CTC 
detection17, 45. However, the accuracy of ex vivo CTC assays is open to question because they 
depend on a small sample volume of blood18. In vivo CTC detection can improve sensitivity and 
reliability by accessing a larger portion of the total blood volume17. Many in vivo CTC detection 
studies that employ exogenous agents, such as fluorophore-labeled antibodies, have achieved 
promising results21, but biosafety concerns impede their clinical translation17, 45. Thus, label-free 
detection of CTCs in vivo has attracted great interest. 
In this work, we focus on CTC detection in melanoma, the deadliest type of skin cancer with a 
high propensity for metastasis at even an early stage15, 29, 46. Due to their high melanin expression, 
melanoma cells have a striking endogenous optical absorption contrast against the blood 
background in the red to near-infrared spectrum22. Hence, photoacoustic (PA) imaging, offering 
the highest possible sensitivity to absorption contrast and complying with the ANSI (American 
National Standards Institute) safety standard of skin exposure to laser, is a promising tool for in 
vivo detection and characterization of melanoma CTCs6, 19. 
In our previous work9 (Chapter 2), we employed a non-optimal wavelength of 1064 nm for 
melanoma CTC detection, which was dictated by the wavelength availability of commercial high-
repetition–rate lasers47. Within this constraint, stimulated Raman scattering (SRS) provides a 
convenient and efficient approach to implement multi-wavelength imaging48, 49. Through inelastic 
scattering of photons, this nonlinear process converts the pump laser into multiple discrete output 
wavelengths—Stokes lines50. As described in this letter, we employed a potassium gadolinium 
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tungstate crystal (KGd(WO4)2, or KGW), with a Raman shift at 901.5 cm–1, to partially convert 
the 532 nm pump laser light to KGW’s fourth Stokes line at 658 nm. At 658 nm, the ratio of the 
molar absorption coefficients of melanin to hemoglobin is at least 10 times higher than that at 1064 
nm22, significantly improving detection sensitivity. In addition, we achieved a laser pulse repetition 
rate of up to 1 MHz, owing to KGW’s excellent thermal properties, including its high thermal 
conductivity, high damage threshold, and low thermal lensing49. Employing such a fast laser 
source, we report the development of high-speed dual-wavelength PA flow cytography that has 
successfully imaged the flow of rare single CTCs shed from melanoma xenografts in trunk blood 
vessels. 
3.2 Methods 
In our dual-wavelength PA flow cytography system (Figure 3.1), a 532 nm picosecond-pulsed 
laser (Olive-1064-4 BW, Huaray Precision Laser) was used both to pump the Raman laser and to 
provide the 532 nm imaging laser. In the Raman laser’s path, the pump laser was loosely focused 
into the 30-mm-long KGW crystal (KGW-702, EKSMA OPTICS), and the SRS effect generated 
a series of Stokes lines (Figure 3.2a), described by 𝑁Δ𝜈෤ ൌ ሺ1/𝜆௣ െ 1/𝜆௦ಿሻ. Here, Δ𝜈෤ is the Raman 
shift of the material, while 𝜆௣ and 𝜆௦ಿ are the wavelengths of the pump laser and the 𝑁th order 
Stokes line. Since KGW’s Raman gain coefficient is dependent on the polarization of the pump 
laser, a half-wave plate (WPH05M-532, Thorlabs) was placed in front of the KGW to align the 
pump laser’s polarization with the crystal’s a-axis. The output beam was collimated and filtered 
by a band-pass filter (FBH660-10, Thorlabs) to selectively pass the fourth Stokes line at 658 nm. 
Since this high-order Stokes line had relatively large energy fluctuations (Figure 3.2b), it was 
sampled by a fast photodiode (PDA36A, Thorlabs) for pulse-to-pulse energy calibration. In the 
532 nm path, the laser was sent through a 25-m long delay line, then combined with the 658 nm 
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laser by a dichroic mirror (Dichroic Laser Beam Combiner #86-393, Edmund Optics). The 
combined laser beams were focused by an achromatic convex lens (AC127-025-A, Thorlabs), and 
reflected to the tissue by a lab-made MEMS (micro-electro-mechanical systems) scanner. The laser 
energy was converted to acoustic waves through the optical absorption of endogenous absorbers 
and the subsequent thermoelastic expansion. The emitted PA waves were also reflected by the 
MEMS scanner, and then acquired by a polyvinylidene difluoride (PVDF) ultrasonic transducer 
(custom made by CAPISTRANO LABS: 40 MHz central frequency) which has a central hole for 
passing the laser beams. The MEMS scanner angularly steered both the laser beams and the PA 
wave in a confocal configuration during oscillation. Both the MEMS scanner and the PVDF 
transducer were immersed in a tank of deionized water for acoustic coupling. 
The PA signals were amplified by a pair of radio-frequency amplifiers (ZFL-500LN+, Mini-
circuits) and digitized by a data acquisition unit (ATS9350, Alazar Tech) at a 250-MHz sampling 
rate. For raster scanning, fast line scans were performed by the MEMS scanner at a 1 kHz rate 
(round-trip scanning at the 500 Hz resonance frequency), while slow orthogonal scans were 
provided by the motor stage (PLS-85 Precision Linear Stage, PI miCos GmbH) supporting the 
mouse. The 25-m delay line resulted in the 532 nm laser-induced PA signal arriving ~80 ns later 
than that from the 658 nm laser, which was sufficient to temporally resolve the two PA signals. 
The whole system was automated through a reconfigurable input/output module (NI PCI-7830R, 
National Instruments), and operated through an interface programed in LabVIEW. The maximal 
amplitude projection of the volumetric PA data was displayed in real time. 
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Figure 3.1 Schematic of the dual-wavelength high-speed PA flow cytography system. The 532 nm and 658 nm 
lasers are employed to image the vasculature and the melanoma CTCs, respectively. BPF, band-pass filter; DAQ, data 
acquisition unit; UT, PVDF ultrasonic transducer; λ/2, half-wave plate. 
To quantify the performance of our Raman laser, first we used a spectrometer (AvaSpec-
ULS2048XL-EVO, AVANTES) to measure its output spectrum (Figure 3.2a). The linewidth of 
the fourth Stokes line at 658 nm was 2.34 nm when producing ~100 nJ pulse energy at the 1 MHz 
repetition rate. After filtering the laser output with the band-pass filter, we measured the 658 nm 
energy output over 20 min (Figure 3.2b). The result indicated a relative standard deviation of 
7.62% RMS (root mean square), which could be corrected by sampling every pulse with the 
photodiode. The beam profile captured with a CMOS (Complementary metal-oxide-
semiconductor) camera (Grasshopper3 GS3-U3-23S6M, Point Grey) is shown in Figure 3.2c. 
 
Figure 3.2 Performance of the Raman laser. (a) Optical spectrum of the multi-wavelength Raman laser output after 
filtering out the pump laser, plotted on a background of the oxy-hemoglobin (HbO2), deoxy- hemoglobin (HbR), and 
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melanin absorption spectra. AS, the anti-Stokes line; S1–S4, the first to fourth Stokes lines. (b) Long-term stability 
measurement of the 658 nm Raman laser pulse energy. (c) Beam profile of the 658 nm Raman laser. 
3.3 Results 
To demonstrate our Raman laser-based PA flow cytography’s capability to image melanoma CTCs 
on the fly, we imaged areas near a xenograft tumor in the mouse ear. Experiments were carried out 
in compliance with the laboratory animal protocols approved by the Institutional Animal Care and 
Use Committee of California Institute of Technology. A dose of ~104 B16F10 mouse melanoma 
cells was inoculated into the ear of an athymic nude mouse (Hsd:Athymic Nude-Foxn1nu, Envigo) 
through intradermal injection (Figure 3.3ab). The B16F10 cell line was obtained from American 
Type Culture Collection, and was cultured in Dulbecco’s Modified Eagle Medium, supplemented 
with 10% fetal bovine serum, at 37 °C in a humidified atmosphere with 5% CO2. PA flow 
cytography first imaged the vasculature of the area near the tumor two weeks after inoculation 
(Figure 3.3c), and a region of interest (ROI) was further monitored for over 2 hours at a 20 Hz 
frame rate with a 2.7 µm lateral resolution. Owing to the strong absorption by the hemoglobin in 
red blood cells, the vascular structure was clearly imaged by the 532 nm laser. Exploiting the 
striking absorption contrast between melanin and hemoglobin, the 658 nm laser excitation of a 
single CTC produced a PA signal ~20 times stronger than blood, appearing as a hot spot in the 
dark background (Figure 3.3d). Figure 3.3e shows more snapshots of this CTC flowing in the 
artery. We performed control studies on normal mice and recorded no PA signals of a similar 
amplitude level, which verified that these PA signals indeed originated only from CTC absorption. 
The entire time course of this CTC flowing through the ROI was captured in a video. The arterial 
flow speed of this CTC was calculated to be 0.5 mm/s, which is in general accordance with 
previous reports. 
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Figure 3.3 PA flow cytography of a melanoma CTC. (a) A photo of the melanoma model on the mouse ear at two 
weeks post inoculation. (b) PA image of the inoculated melanoma and its vascular environment at four days post 
inoculation. Scale bars in (a) and (b) represent 100 μm. (c) Flow cytography image of the vasculature near the tumor. 
The blue box indicates the ROI imaged at 20 Hz in the subsequent frames. (d) 532 nm laser-induced (top), 658 nm 
laser-induced (middle), and fused (bottom) flow cytography images showing a melanoma CTC flowing in the artery, 
as indicated by the yellow arrows. The CTC has a typical contrast-to-noise ratio of ~60. The trunk artery’s and vein’s 
boundaries are delineated by the red and blue dashed lines, respectively. (e) Three fused snapshots showing this CTC, 
illustrated by the yellow arrows, traveling in the artery. The labeled times are relative to the first frame containing this 
CTC. 
3.4 Discussion 
In summary, we report high-speed PA flow cytography based on a 1 MHz repetition rate Raman 
laser. Compared to our previous work in Chapter 2, we achieved a 4-fold improvement in the 
contrast-to-noise ratio, and a 5-times increase in imaging speed. This improvement enabled us to 
continuously monitor the flow of rare CTCs shed from tumor xenograft models in vivo, instead of 
coincidentally imaging CTCs only when they completely overlapped with the probing laser. This 
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PA flow cytography system complies with the ANSI safety standard, and is readily translatable to 
clinics. It can provide valuable information for predicting a melanoma’s recurrence risk The 
Raman laser approach overcomes the wavelength limitation of the commercially available laser 
sources for high-speed multi-wavelength imaging. Compared to previously reported fiber-based 
Raman lasers, our free-space approach offers convenient system operation, adjustment, and 
upgrading. For example, by simply switching the 532 nm pump laser output to its fundamental 
mode at 1064 nm, this system can also perform multi-wavelength imaging in the near-infrared 
region, such as imaging lipid-rich neuron networks at 1177 nm and 1726 nm (the 1st and 4th Stokes 
lines of KGW when pumped at 1064 nm, respectively). It is also very easy to switch to other 
Raman materials with different wavelength outputs, such as barium nitrite (Ba(NO3)2, with a 
Raman shift at 1048.6 cm–1), further extending the scope of this study. At present, we can achieve 
a sufficient imaging speed over only a relatively small field of view, so further work should address 
this limitation by employing techniques such as multi-focal imaging. 
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Chapter 4: Fast initial dip in mouse brains 
from a single stimulus imaged in single 
vessels by Raman-laser–based dual-
wavelength high-speed functional 
photoacoustic microscopy 
This chapter describes a new application of the wavelength conversion technique introduced in 
Chapter 3, stimulated Raman scattering, in the field of high-speed functional PAM. Considered as 
a spatiotemporally confined indicator for poststimulus neural activities, the initial dip holds great 
promise for neurological studies51-53. However, existing technologies still cannot fully reveal its 
detailed mechanism or profile, mainly because they failed to directly probe it at its microvascular 
origins54. Here we present Raman-laser–based dual-wavelength high-resolution functional 
photoacoustic microscopy (fPAM) that can image capillary-level hemodynamics at a 1 MHz one-
dimensional imaging rate. We investigated the mouse brain vascular response to impulse forepaw 
stimulations, revealing a transient initial dip of blood oxygenation (sO2) in cerebral micro-vessels 
starting as early as 0.13 s poststimulusly, preceding the total hemoglobin changes. The recovery 
from the initial dip and the subsequent sO2 overshoot manifested a spatiotemporal pattern similar 
to the stimulation-activated hyperemic response, suggesting their close relations. Our fPAM sheds 
new light on this elusive initial dip phenomenon, and it is a valuable tool for functional studies 
requiring high spatiotemporal resolution. 
4.1 Background 
In the ongoing effort to decode our brain, functional imaging of small animals has been a hot topic 
in various biomedical imaging fields. Label-free imaging technologies often non-invasively probe 
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neural activities in an indirect manner3, 55, such as measuring the stimulation-induced hyperemic 
response, which undergoes spatiotemporal broadening from neuronal activation sites56, 57. The 
initial dip, thought to be caused by increased oxygen consumption from activated neurons51, 52, 58, 
59, is considered to be a both spatially and temporally more confined localizer for the neural activity 
than the hyperemic response57, 58, 60-62, and has attracted profound interest63-67 since its discovery 
by diffuse optical spectroscopy68. Two label-free imaging techniques, functional magnetic 
resonance imaging52, 65, 66 (fMRI) and wide-field optical microscopy59, 60, 63, have both made 
valuable contributions to the understanding of the initial dip. However, small-animal fMRI lacks 
the spatial resolution to discern the dynamics of cerebral micro-vessels with diameters less than 
50 µm54, where the initial dip is thought to originate57, 58. Wide-field optical microscopy, in theory, 
has sufficient spatial resolution, but suffers from heavy round-trip optical scattering and low 
sensitivity when resolving deep vessels, because it relies on back-scattered photons from red blood 
cells69 (RBCs). It also lacks the depth resolution70. As a result, the initial dip phenomenon is still 
not fully understood52, 61, 64. 
Label-free functional photoacoustic microscopy (fPAM), with optical diffraction-limited spatial 
resolution, offers unique advantages to overcome these bottlenecks71, such as rich optical 
absorption contrast and volumetric imaging capability from single-plane scanning3. Through the 
photoacoustic (PA) effect3, fPAM ultrasonically detects photons absorbed by endogenous 
absorbers, like hemoglobin in RBCs, thus making it more sensitive to hemodynamics than pure 
optical imaging because hemoglobin’s optical absorption is much stronger than scattering. Also, 
since ultrasonic scattering in biological tissues is 2–3 orders of magnitude weaker than optical 
scattering72, fPAM can achieve greater penetration depth than wide-field optical microscopy, 
enabling imaging the dynamics of deep cortical micro-vessels3. 
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Here we report Raman-laser–based dual-wavelength fPAM employing the spectroscopic method 
for blood oxygen saturation (sO2) measurement73. Conforming to the American National Standards 
Institute’s (ANSI) safety standard, our fPAM has achieved high-sensitivity volumetric imaging at 
a 1 MHz one-dimensional (1D) rate with 2.7 µm lateral and 30 µm axial resolutions, revealing 
capillary-level cerebral vascular dynamics. We imaged the somatosensory area of mouse brains, 
and clearly observed a transient initial sO2 dip from micro-vessels shortly after stimulating the 
forepaw. To the best of our knowledge, this is the first time that the initial dip has been directly 
imaged at the single-capillary scale, and our data provide new insights on this elusive phenomenon. 
4.2 Methods 
4.2.1 Raman laser 
This section details the Raman laser technique first introduced in section 3.2. A Raman laser 
utilizes the SRS effect as the mechanism of light amplification. Stokes lines are generated by the 
pump laser through inelastic scattering. The energy difference between the pump photons and the 
scattered photons is fixed and related to a vibrational frequency of the Raman medium. Equation 
(4.1) is used to calculate the wavelength of the 𝑁th order Stokes line50. Since the Raman shift, Δ𝜈෤, 
is generally reported in wavenumbers (cm–1), unit conversion is explicitly expressed here: 
 𝑁Δ𝜈෤ሺcmିଵሻ ൌ ሺ1/𝜆௣ ሺnmሻ െ 1/𝜆௦ಿሺnmሻሻ ൈ ሺ10଻nm/cmሻ 4.1 
where 𝜆௣ and 𝜆௦ಿ are the wavelengths of the pump laser and the 𝑁th order Stokes line, respectively. 
For a Raman crystal of a length of L and a Raman gain coefficient of 𝑔ோ, the output power 𝑃௦ of 
the first Stokes line is described as 
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 𝑃௦ ൌ 𝜂𝑃௣ exp ൬ 𝑃௣𝐴ୣ୤୤ 𝑔ோ𝐿ୣ୤୤ െ 𝛼௦𝐿൰ 4.2 
where 𝑃௣ is the power of the pump laser; 𝐴ୣ୤୤ is the effective area of the pump light incident on the 
crystal; 𝐿ୣ୤୤ ൌ ሺ1 െ exp ሺ𝛼௣𝐿ሻሻ/𝛼௣ is the effective length of the crystal; and 𝛼௣ and 𝛼௦ are the 
crystal’s attenuation coefficients for the pump laser and the first Stokes line, respectively. The term 
𝜂𝑃௣ represents the initial spontaneous Raman scattering at the input end of the crystal functioning 
as the seed for SRS, with 𝜂 denoting the conversion rate. To achieve the SRS effect, the exponential 
term must be greater than 1, requiring a threshold of pump power at 𝑃୲୦ ൌ 𝛼௦𝐿𝐴ୣ୤୤/𝑔ோ𝐿ୣ୤୤. As 
seen in Equation (4.1), the energy conversion efficiency exponentially increases with pump 
intensity 𝑃௣/𝐴ୣ୤୤. However, for maximizing the output power and stability at the first Stokes line 
of 558 nm, its power should not exceed the threshold for generating the second Stokes line. 
Therefore, the pump intensity should be controlled within the following range74: 
 𝑃௣𝐴ୣ୤୤ ∈ ൤
𝛼௦𝐿
𝑔ோ𝐿ୣ୤୤ ,
30
𝑔ோ𝐿ୣ୤୤൨ 4.3 
where the upper limit is calculated by using a typical value of 10–7 for 𝜂. 
4.2.2 MEMS scanner 
This section describes the design and fabrication of a new MEMS scanner that has a better 
performance and smaller size than that in Chapter 2. This new torsional MEMS scanner consists 
of five major components: a 5 × 7 mm2 mirror (custom made by Biomedical-Optics, silver coating 
and SiO2 overcoating), a frame cut from a thin sheet of spring-tempered stainless steel (material 
and laser cutting provided by Potomac-laser), a permanent magnet (B222G-N52, K&J Magnetics), 
an inductor coil wrapped from 32 gauge magnet wires (Guasti Wire), and a hollow stainless steel 
mount for the assembly (custom made by eMachineShop) (Figure 4.1a). The frame consists of a 
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rectangular center plate of the same size as the mirror, two outer wings, and two hinges connecting 
the wings to the central plate. To assemble the scanner (Figure 4.1b), first, the mirror and the 
magnet were glued to the front and back sides of the frame’s center plate, forming the scanning 
part. Second, the inductor coil was glued to the inner surface of the mount, forming the stationary 
part. Finally, the scanning part was fixed on the mount by fastening the frame’s wings to the front 
surface of the mount. For underwater usage, marine grade epoxy was used to glue the components 
together. All components were centrally aligned during assembly, and the magnet's direction was 
aligned with the long side of the rectangular mirror. 
The movement of the mirror is controlled by driving a sinusoid electrical current (provided through 
a differential amplifier: TDA7266 audio amplifier module, Shenzhen LC Technology) through the 
inductor coil (Figure 4.1c). In Newtonian mechanics, the resonance frequency 𝑓 of the MEMS 
scanner can be calculated by solving a second-order differential equation obtained by Newton’s 
second law and Hooke’s law75: 
 𝐾௦𝜃 ൌ െ𝐼௠dଶ𝜃/d𝑡ଶ  4.4 
where 𝜃 is the deflection angle of the hinge; 𝐾௦ is the spring constant of the hinge, which is related 
to the hinge’s structure and the torsional modulus of its material; and 𝐼௠ is the moment of inertia 
of the scanning part, which is determined by its distribution of mass relative to the hinge. The 
solution of 𝜃 gives the scanner’s resonance frequency 𝑓 as 
 𝑓 ൌ 12𝜋 ඥ𝐾௦/𝐼௠  4.5 
Equation (4.5) assumes a friction-free operation. When the scanner works underwater, the 
resonance frequency 𝑓୵ is described by 
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 𝑓୵ ൌ 𝑓√1 െ 𝛿  4.6 
where 𝛿 is a damping factor related to the shape of the scanning part and the properties of water. 
 
Figure 4.1 Schematic of the MEMS scanner. (a) Breakdown of the MEMS scanner. The scanning part of the scanner 
is comprised of the mirror, the center plate of the frame, and the permanent magnet. The stationary part is comprised 
of the two wings of the frame, the inductor coil, and the mount. The scanning part is connected to the stationary part 
via the two hinges of the frame. (b) Assembly view of the MEMS scanner. (c) Top and sectional views of the finished 
MEMS scanner. The actuation force is generated by the electromagnetic interaction between the electrical current 
through the inductor coil and the permanent magnet. 
To achieve a desired resonance frequency, one may either adjust 𝐼௠ by grinding the magnet to a 
certain thickness or adjust 𝐾௦ by varying the structure of the hinge. 
4.2.3 fPAM 
The high-speed PAM system here employs a novel detection scheme with superior sensitivity 
compared to that in section 2.2. The details are described here. Two 532 nm picosecond-pulsed 
lasers (laser 1 in Figure 4.2a: Olive-1064-4 BW, Huaray Precision Laser; laser 2 in Figure 4.2a: 
APL-4000-1064, Attodyne Lasers) were employed in this dual-wavelength fPAM system, one 
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each for the 558 nm path and the 532 nm path, respectively. In the 558 nm path, the pump laser 
beam was loosely focused into the 30-mm-long KGW crystal (KGW-702, EKSMA OPTICS; b-
cut), and the SRS effect partially converted the 532 nm pump photons to the first Stokes line at 
558 nm. Since the Raman gain coefficient of KGW is dependent on the polarization of the pump 
laser, a zero-order half-wave plate (WPH05M-532, Thorlabs) was used to align the pump laser’s 
polarization with the a-axis of the KGW crystal. The output beam was collimated by another lens 
and filtered by a band-pass filter (575/25 nm BrightLine, Semrock) to selectively pass the first 
Stokes line. In the 532 nm path, the laser beam was expanded and collimated by a pair of convex 
lenses. The 558 nm and 532 nm laser beams were combined by a dichroic mirror (Dichroic Laser 
Beam Combiner #86-393, Edmund Optics), focused by an achromatic lens (AC127-025-A-ML, 
Thorlabs), and reflected into the tissue by the lab-made MEMS scanner. PA waves excited by the 
laser pulses were also reflected by the MEMS scanner, and converted to electrical signals by a 
PVDF ultrasonic transducer (custom made by CAPISTRANO LABS: 40 MHz central frequency, 
110% –6 dB bandwidth). Instead of using a complex optical-acoustic splitter, which has a low 
acoustic transmission efficiency, as in previous PAMs9, 71, 76, we maintained the confocal 
configuration of the laser beams and the PA waves by passing the laser beams directly through the 
central hole of this ring-shaped PVDF transducer. Both the MEMS scanner and the transducer 
were immersed under deionized water in a water tank for acoustic coupling. The water tank, which 
had transparent windows on its side and bottom for light and acoustic wave transmission, was 
placed on top of the tissue with its bottom window in gentle contact with the acoustic gels applied 
on the tissue surface. The PA signals acquired by the transducer were then amplified by a pair of 
radio frequency amplifiers (ZFL-500LN+, Mini-circuits), and digitized by a fast data acquisition 
unit (ATS9350, Alazar Tech) at a 250-MHz sampling rate. For laser pulse energy calibration, a 
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photodiode (PDA36A, Thorlabs) was used to sample the laser beams, which were split by a 
wedged optical window (34-245, Edmunds Optics). The MEMS scanner was connected to a 
stepper motor, and the mouse was also supported by a motor-driven translation stage. For raster 
scanning, fast line scans were performed by the MEMS scanner at a 1 kHz rate (500 Hz resonance 
frequency), while slow orthogonal scans were provided by one of the two motors. The motor stage 
supporting the mouse was used for the wide-field-of-view (FOV) scanning (Figure 4.2e), and the 
stepper motor supporting the MEMS scanner was used for the narrow-FOV scanning. The system 
was automated by a field programmable gate array (NI PCI-7830R, National Instruments), and 
operated through an interface programmed in LabVIEW. 
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Figure 4.2 fPAM of the mouse brain. (a) Schematic of the fPAM system. λ/2: half-wave plate; BPF: band-pass 
filter; DAQ: data acquisition unit; UT: ultrasonic transducer. (b) Spectrum of the Raman laser plotted on the 
background of hemoglobin absorption spectra. HbO2 and HbR: oxy- and deoxy-hemoglobin, respectively. (c) Scheme 
for the functional study. Imaging is performed continuously over an area in the somatosensory region enclosed by the 
blue square in d, while the mouse receives impulse stimulation to either one of its forepaws alternatingly. The 
stimulation-induced sO2 response starts with a sharp decrease, the initial dip, followed by an overshoot (inset in c). 
(e) A representative MAP image of the somatosensory region. (f) The depth-encoded image of e. 
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In order to separate the two PA signals from the 532 nm and 558 nm laser pulses, Laser 2 was 
triggered 0.5 µs later than Laser 1. This 0.5-µs interval allowed the earlier PA wave to travel ~0.75 
mm (greater than the maximum penetration depth of this fPAM system), and such a short interval 
also ensured that the two laser beams sufficiently overlapped in the focal plane during scanning. 
The system’s lateral resolution was optically defined at 2.7 µm. The axial resolution (along the 
acoustic axis) was ~30 µm, which was jointly determined by the laser pulse width, the frequency-
dependent acoustic attenuation in tissue, and the frequency response of the ultrasonic transducer77. 
In our previous fPAM, the confocal alignment of the laser beams and the PA waves was achieved 
through an optical-acoustic splitter, which had a low efficiency for both optical and acoustic 
transmissions. Here, we circumvent this issue by employing a PVDF transducer with a hollow core 
for direct laser passage. The acoustic impedance of PVDF matches better with the tissue-coupling 
water than the piezoelectric ceramic transducer used in the previous version, which improves 
acoustic transmission efficiency. Further, PVDF transducers often offer a broader bandwidth than 
ceramic transducers, improving the axial resolution of PAM. 
The sO2 measurement in the previous work was based on optical absorption saturation, thus 
requiring a laser exposure exceeding the ANSI safety limit. Here, we employ the more established 
spectroscopic method for measuring sO2. For in vivo brain imaging, the laser exposure on the tissue 
surface is 18 mJ/cm2, within the ANSI standard, making it safe for future human imaging. Unlike 
several previously reported systems in which the scanners were made of proprietary materials or 
required expensive machining equipment, the MEMS scanner we developed here was fabricated 
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entirely from commercially available parts using common engineering tools, facilitating 
replication. We also achieved a 5-fold increase in imaging speed. 
In summary, compared to the previous fPAM, our system’s detection sensitivity is improved due 
to the low acoustic signal loss, despite the PVDF transducer being less sensitive than traditional 
ceramic transducers. The spectroscopic method employed here for the sO2 measurement does not 
require optical absorption saturation. Therefore, our sO2 mapping is also more robust, especially 
for deep vessels where the light attenuation is too strong to safely satisfy optical absorption 
saturation. 
4.2.4 Data processing 
We employed the Hessian-based vasculature enhancement filter to extract the blood vessels from 
our fPAM images78. The enhanced image was used to create a binary mask of vessels, which was 
applied to the raw images to remove non-vessel structures, such as residual blood stains on the 
brain. 
The PA signal amplitude is linearly proportional to the local concentrations of oxy- and deoxy-
hemoglobins, as described here73: 
൤PAହଷଶ ୬୫/Fହଷଶ ୬୫PAହହ଼ ୬୫/Fହହ଼ ୬୫൨ 𝐾 ൌ ቈ
𝜀ୌୠୖሺ532 nmሻ 𝜀ୌୠ୓మሺ532 nmሻ
𝜀ୌୠୖሺ558 nmሻ 𝜀ୌୠ୓మሺ558 nmሻ቉ ቂ
𝑐ୌୠୖ𝑐ୌୠ୓మቃ , 4.7 
where PA represents the PA signal amplitude; F denotes the local optical fluence; 𝜀 is the molar 
absorption coefficient; 𝑐 represents the local molar concentration; K is the system’s proportionality 
coefficient relating the normalized PA signal to the absorption coefficient; and the subscript 
denotes the wavelength or the form of hemoglobin. Since 𝐾 is unknown, only relative 
concentrations can be obtained. Least-squares fitting gives the solution as 
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ቂ 𝑐ୌୠୖ𝑐ୌୠ୓మቃ ൌ ሺ𝑀
்𝑀ሻିଵ𝑀் ൤PAହଷଶ ୬୫/Fହଷଶ ୬୫PAହହ଼ ୬୫/Fହହ଼ ୬୫൨ 𝐾, sOଶ ൌ
௖ౄౘోమ
௖ౄౘోమା௖ౄౘ౎
, 4.8 
where 𝑀 is the matrix in Equation (4.7). 
The total hemoglobin concentration change was extracted from the 532 nm images, because this 
wavelength is an isosbestic point for the two forms of hemoglobin. Because dynamics caused by 
heartbeat were clearly evident from the PA traces, hemodynamic responses were extracted after 
low-pass filtering (Figure 4.3). Vessel diameters were measured as the shortest line across a vessel 
at different angles, with vessel boundaries identified using the 3σ threshold. 
 
Figure 4.3 Extraction of total hemoglobin concentration changes. The blue line is the raw signal from line 
scans with the 532 nm laser. The fractional change, shown by the dashed line, is obtained by filtering out 
the heartbeat dynamics with low-pass filters. The red bar on the horizontal axis denotes the stimulus 
instant. 
4.2.5 Experimental animals 
Female ND4 Swiss Webster mice (Hsd:ND4, Envigo; 6–8 weeks old) were used for the animal 
experiment. The laboratory animal protocols were approved by the Institutional Animal Care and 
Use Committee of California Institute of Technology. First, the mouse was anesthetized with 
isoflurane, then taped to an animal holder with its head tightly fixed by a stereotaxic frame. Its 
body temperature was kept at 37 °C by a heating pad. Second, the scalp was surgically removed, 
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and the skull above the area roughly corresponding to the forepaw of the somatosensory cortex 
(S1FL region) was carefully thinned to a thickness of ~50 µm. Ultrasound gel was then applied on 
the brain to retain moisture and couple the acoustic waves. After the surgery, anesthesia was 
transferred to α-chloralose by an intraperitoneal injection of a dosage at 50 mg per kg body weight 
every two hours. Anesthesia depth was carefully controlled by monitoring the heart rate, 
respiration rate, and hindpaw pinch reflex. Next, a water tank filled with deionized water was 
placed on top of the mouse head. The plastic membrane at the bottom of the water tank was in 
gentle contact with the ultrasound gel applied on the brain. Finally, the mouse was placed under 
the fPAM for imaging. For high-frame-rate narrow-FOV imaging, as in Figure 4.8c, raster 
scanning was provided by the MEMS scanner and the stepper motor connected to the MEMS 
scanner. Therefore, the mouse remained in a natural motionless state. 
4.2.6 Electrical stimulation protocol 
Electrical stimulations were introduced by two pairs of needle electrodes inserted under the skin 
of the right and left forepaws. The electrodes were connected to a stimulator (Isolated Pulse 
Stimulator Model 2100, A-M Systems) for providing the electrical stimuli. A stimulation sequence 
consisted of a 60-s rest period, a single strong but brief electrical pulse to one of the forepaws, and 
a 50-s rest period. This electrical stimulus had an amplitude of ~2 mA and a pulse width of 40 ms. 
Next, the same stimulation was applied to the other forepaw (Figure 4.2c). This sequence was 
repeated five times, with a 1.0–1.5 min gap in between. The stimulation period and intensity were 
controlled without inducing noticeable motions. We employed a single brief stimulus instead of a 
pulse train since the initial dip is a fast response that can be confounded by multiple stimuli. 
Moreover, this stimulation scheme is also used in some other initial dip studies59, 79. 
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4.3 Results  
4.3.1 Imaging results 
Our fPAM employs two laser wavelengths, 532 nm and 558 nm, to measure the vascular sO2 in 
mouse brains (Figure 4.2a). We utilize a Raman crystal, potassium gadolinium tungstate 
(KGd(WO4)2, or KGW; Raman shift: 901.5 cm-1), to convert a 532 nm picosecond-pulsed pump 
laser to KGW’s first Stokes line at 558 nm through the SRS effect, with ~40% efficiency. The 
resulting 558 nm Raman laser has a linewidth of ~0.5 nm (Figure 4.2b) and a relative pulse energy 
deviation of 1.64% RMS (root mean square) when producing ~150 nJ pulses at a 1 MHz pulse 
repetition rate (Figure 4.4), indicating good monochromaticity and stability. A second 532 nm 
picosecond-pulsed laser provides the 532 nm laser beam. The two laser beams are combined and 
focused into the tissue to excite PA waves from hemoglobin in RBCs. 
 
Figure 4.4 Stability test of the 558 nm first Stokes line output. The laser pulse energy was sampled by a high-speed 
photodiode (DET10A, Thorlabs). 
To acquire the PA waves, we employ a ring-shaped piezoelectric polyvinylidene fluoride (PVDF) 
transducer that has a central hole for laser passage. During raster scanning, both the laser beams 
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and PA waves are confocally steered at up to a 1 kHz line scan rate by a lab-made MEMS 
(microelectromechanical system) scanner, assembled entirely from commercially available 
components (Figure 4.1). The PA signals acquired by the transducer are amplified by a pair of 
radio frequency amplifiers, then digitized by a data acquisition unit at up to a 1 MHz A-line rate. 
Maximum amplitude projection (MAP) images are displayed in real time. 
 
Figure 4.5 Lateral resolution measurement of fPAM. (a) PA image of a blade. (b) The edge spread function (ESF) 
is extracted by fitting the blade image data with an error function. The line spread function (LSF) is computed as the 
first derivative of the ESF. Lateral resolution is defined as the full width at half maximum of the LSF. 
Our fPAM has achieved a lateral resolution of 2.7 µm (Figure 4.5) and a signal-to-noise ratio of 
33.2 dB while imaging single RBCs in the cerebral vasculature through a thinned skull (Figure 
4.6). The relative concentrations of oxy- and deoxy-hemoglobin are calculated by spectral analysis 
of the PA images acquired at 532 nm, a near isosbestic wavelength of hemoglobin, and at 558 nm, 
a nonisosbestic wavelength. Fractional changes in total hemoglobin concentration (HbT) are 
extracted from the images acquired at 532 nm (Figure 4.3). 
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Figure 4.6 Imaging of cerebral blood vessels, showing individual RBCs. In this experiment, the mouse brain was 
pressed firmly against the membrane at the bottom of the water tank to facilitate discontinuous flows of RBCs. 
Using our fPAM, we studied the mouse brain hemodynamic response to electrical stimulations by 
monitoring both sO2 and HbT simultaneously (Figure 4.2c). First, we imaged over an area of the 
somatosensory cortex through a thinned skull (Figure 4.2de). We acquired 3D images with an 
imaging depth of up to 0.5 mm in a single raster scan (Figure 4.2f, and Figure 4.7). 
 
Figure 4.7 Representative PA image of cerebral vasculature projected onto the coronal plane. Volumetric data 
is obtained by single-plane scanning with the depth axis resolved by the times of flight of PA signals. 
By fixing the optical focus at ~300 µm below the skull, the structure and oxygenation of capillaries 
as deep as Layer III of the cortex were clearly mapped (Figure 4.8a). In the resting state, the sO2 
in the micro-vessels decreased by ~15% per 100 µm along the vessel (Figure 4.8b), consistent with 
literature reports6. Next, a region of interest, illustrated by the blue square in Figure 4.8a, was 
monitored at a 6 Hz imaging rate while the mouse received brief electrical stimuli at its forepaws. 
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Our high-sensitivity and high-speed fPAM successfully resolved subtle and transient responses 
from micro-vessels. 
 
Figure 4.8 fPAM of cerebral vascular response to electrical stimulations. (a) sO2 mapping of the somatosensory 
area in the resting state. The blue rectangle illustrates the region of interest for the subsequent functional imaging 
studies. (b) Oxygen release along a cerebral vessel marked with the white dashed line in a. A plateau, indicated by the 
arrow, is the site where the blood from another capillary flows into this vessel. (c) Timing of the initial dip onset 
(defined by 3σ) superimposed onto the grayscale structure image. (d) Timing of the initial dip trough. (e) Fractional 
change of the trough of the initial dip. (f) Timing of the hyperemic response onset. Data in (c–f) are averaged over 
five trials. 
Upon contralateral stimulation, the sO2 from capillaries, venules and small arterioles exhibited a 
two-phase response: a sharp and short decrease, then a recovery and a small overshoot. The 
hypoxic phase, the initial dip, started shortly after the stimulus nearly simultaneously across all 
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micro-vessels in the core response area (Figure 4.8c and Figure 4.9), but the trough of the initial 
dip demonstrated a propagation pattern from upstream arterioles to capillaries and further down to 
venules (Figure 4.8d). Similarly, the hyperoxic phase from upstream arterioles and capillaries 
notably preceded that of the downstream venules. Both the hypoxic and hyperoxic phases from 
capillaries had a greater fractional change than those from larger vessels (Figure 4.8e). The trough 
of the initial dip was followed by the hyperemia resulted from neurovascular coupling (Figure 
4.8f), and its spatiotemporal distribution closely mirrored that of the hyperoxic phase. We also 
observed some arteriole dilation co-localized with the hyperemia. 
 
Figure 4.9 Statistical analysis of the hemodynamics in four vessel segments representative of the different 
microvascular compartments. Venule 1 and venule 2 denote postcapillary and second-stage venules, respectively. 
Data are averaged over five trials on each of the five mice; error bar, standard error; statistics, paired Student’s t-test; 
P values, *** < 0.001; ** < 0.05. 
4.3.2 Line scan results 
Next, we performed fast line scans for 2D imaging across representative vessel segments from 
different microvascular compartments (arrows in Figure 4.8a) to acquire finer temporal profiles of 
the impulse response (Figure 4.10). Figure 4.10a shows a representative single-trial sO2 response 
to an impulse somatic stimulation. The initial dip started first in capillaries (Figure 4.10b), with 
the onset time averaged over five mice being 0.13 ± 0.01 s (all time points are relative to the 
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beginning of the stimulus). The initial dip onset in other microvascular compartments occurred 
only up to 0.05 s later than that in capillaries, and it reached the trough at 0.4–0.7 s, with the trough 
from venules arriving ~0.3 s later than that from precapillary arterioles (Figure 4.10c). The 
capillary has a trough fractional change of up to 8%, which is more than twice that of the arteriole 
but only ~20% greater than that of the postcapillary venules (Figure 4.10d). Second-stage venules, 
the venules joined by postcapillary venules, also had an initial dip with a significantly longer 
duration than capillaries and arterioles, probably due to the out-of-phase influx of deoxygenated 
blood from different capillaries. Following the trough, the sO2 levels quickly recovered, and 
capillaries and venules manifested a weak and flat overshoot, which was insignificant in arterioles 
(Figure 4.10c). 
 
Figure 4.10 Temporal profiles of vascular response. (a) A representative single-trial capillary sO2 time course in 
response to an impulse stimulus. The raw data (blue line) is filtered with a Bessel low-pass filter (25 Hz cutoff 
frequency) to produce the orange curve. We chose the Bessel filter because it preserves the wave shape of the filtered 
signal in the passband and therefore maintains causality. (b) Comparison of the time courses of sO2 and HbT of the 
capillaries. By applying the threshold of 3σ, the onset times of the sO2 and HbT responses are calculated as 0.13 and 
0.46 s, respectively. (c) Time courses of the sO2 fractional changes in four vessel segments representative of the 
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different microvascular compartments. An example of these representative segments is illustrated by the color-coded 
arrows in Figure 4.8a. (d) Initial dip amplitude versus vessel diameter for precapillary arterioles, capillaries, and 
postcapillary venules. Data in (b and c) are averaged over five trials on each of the five mice; data in (d) are averaged 
over five trials; the stimulus is illustrated by the small red bar on the horizontal axis; venule 1 and venule 2 denote 
postcapillary and second-stage venules, respectively; error bar shows standard error. 
This overshoot phase lasted up to 2 s in venules. The hyperemia started first at the arteriole around 
0.4 s, slightly ahead of the trough of the initial sO2 dip in all compartments of the vessel (Figure 
4.10b and Figure 4.11). Its peak amplitudes at the arteriole and capillary were similar, while 
venules had a weaker response but of a longer duration. The tail of hyperemia closely coincided 
with that of the overshoot phase of sO2 response (Figure 4.10b), indicating a strong relation 
between them. 
 
Figure 4.11 Time courses of the HbT fractional changes in four vessel segments representative of the different 
microvascular compartments. An example of these four stages is illustrated by the arrows in Figure 4.8a. Data are 
averaged over five trials on each of the five mice; the stimulus is illustrated by the small red bar on the horizontal axis; 
error bars show standard errors. 
Meanwhile, the ipsilateral stimulation resulted in only a hyperoxic response in sO2 and a 
hyperemia of a smaller amplitude, which occurred at a time point similar to that resulting from 
contralateral stimulations (Figure 4.12). 
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Figure 4.12 Comparison of vascular responses in the core response areas. (a) Trough amplitude of initial dips 
from contralateral and ipsilateral stimulations. (b) Peak value of the sO2 overshoot. (c) Peak value of the hyperemic 
response. Data are averaged over five trials on each of the five mice; error bar, standard error; statistics, paired 
Student’s t-test; P values, *** < 0.001. 
4.4 Discussion 
Since functional imaging often indirectly probes neural activities through measurements of 
hemodynamics, correct interpretation of the imaging data is crucial. Considerable research has 
been devoted to the initial dip, which is thought to be directly related to the local neural 
metabolism. However, despite being frequently observed and extensively studied by various 
imaging/spectroscopy modalities, its details remain inconclusive. Our experimental results provide 
a new and unique perspective on this initial dip phenomenon at high spatial and temporal 
resolutions. fPAM data showed that the initial sO2 dip started as early as 0.13 s after the stimulus. 
Considering a typical value of ~4 × 10–5 cm2/s for the oxygen diffusion constant in tissue80, an 
extra-vascular hypoxic gradient would travel ~33 µm in 0.13 s, which is consistent with the general 
capillary density81. Excluding large venules that collect hypoxic blood, only vessels smaller than 
~30 µm in diameter demonstrated a first-time initial dip, likely due to the ability to release oxygen. 
These two findings support the theory that the initial dip is the result of increased oxygen 
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consumption from activated neurons. Poststimulus hyperemia started slightly ahead of the trough 
of the initial dip, and propagated like the hyperoxic phase of the sO2 response, likely contributing 
to the sO2 recovery and overshoot. 
Our motivation for developing a Raman laser was the limited choices of wavelengths for high-
repetition-rate lasers47, 82. SRS effectively shifts the laser wavelength, with a conversion efficiency 
usually one order of magnitude higher than commercial optical parametric oscillator systems83. 
Compared to other popular Raman materials, KGW possesses many desirable features49, such as 
convenient operation, a high Raman gain coefficient, a high thermal damage threshold, high 
thermal conductivity, and low thermal lensing, of which the last two factors are most critical for 
developing stable high-repetition-rate Raman lasers. Our free-space Raman laser also achieves 
better monochromaticity than fiber-based versions84, 85. The ultralow threshold of KGW enables 
the system to conduct simultaneous imaging at more than two wavelengths by employing 
additional higher-order Stokes and anti-Stokes lines. For example, melanoma progression and its 
hypoxia environment can be monitored by our fPAM working simultaneously at 532 nm, 558 nm, 
and 658 nm (4th Stokes line), further extending the scope of this study. 
In summary, we developed a dual-wavelength fPAM based on a Raman laser at a 1 MHz 1D 
imaging rate. Through direct imaging of oxygenation in individual vessels with optical absorption-
based contrast and high spatiotemporal resolution, fPAM achieved sensitivity and specificity 
superior to other imaging/spectroscopy modalities. We acquired detailed mapping of the 
hemodynamics at the micro-vessel level, which is unattainable for traditional optical imaging or 
fMRI. In vivo experiments quantified the transient initial dip from cerebral micro-vessels, 
providing new insights on this elusive phenomenon. Its multi-wavelength imaging capability may 
benefit many preclinical and clinical applications, such as tumor microenvironment studies. 
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Although advances in fPAM have opened avenues for in vivo biomedical studies, at present, our 
fPAM has a lower imaging speed than fMRI or optical microscopy for wide-field imaging, and 
future studies should address this issue by exploiting techniques like multi-focal imaging. Imaging 
awake animals with a wearable version of fPAM can be another important avenue of exploration. 
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Chapter 5: Transparent high-frequency 
ultrasonic transducer for photoacoustic 
microscopy application 
Chapter 4 introduces a high-speed dual-wavelength fPAM system for functional imaging of the 
mouse brain. This system successfully resolved transient hemodynamic changes on a single micro-
vessel level. However, limited by its sizable optical scanning and ultrasonic detection devices, its 
applications are limited to imaging anesthetized animals. Moreover, anesthetics are found to have 
some profound effect on brain activities86, 87. Thus, there is a need for microscopy technologies 
capable of imaging hemodynamics in awake animals in order to study the natural brain activities. 
Among potential solutions, wearable microscopes present a promising approach. In this work, we 
report development of a thin-film optically transparent high-frequency ultrasonic transducer using 
lithium niobate single-crystal and indium-tin-oxide electrodes, presenting an excellent optical 
transparency of up to 90% in the visible to near infrared spectrum. The center frequency of the 
transducer was at 36.9 MHz with 33.9% –6 dB fractional bandwidth. Imaging capability of the 
fabricated transducer for photoacoustic microscopy was also demonstrated by successfully 
imaging a resolution target and mouse ear vasculature in vivo, which were irradiated by a 532 nm 
pulsed laser transmitted through the transducer. This transparent transducer holds great promise 
for wearable PAM applications. This work was done in collaboration with Dr Qifa Zhou’s lab in 
University of Southern California. 
5.1 Background 
Photoacoustic tomography (PAT) remains the prime choice for label-free imaging of the optical 
absorption contrast in tissue3, 4, 88. It can extract the three-dimensional information of a wide range 
of endogenous absorbers, such as hemoglobin, melanin and cytochrome4. To construct the 
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absorption-based images, PAT detects the ultrasonic waves converted from absorbed optical 
energy through thermoelastic expansion2, 3. Photoacoustic microscopy (PAM), the microscopic 
version of PAT, usually employs a single high-frequency ultrasonic transducer to acquire the 
photoacoustic waves2. So far, the most widely used PAMs for in vivo animal and human imaging 
utilize a reflection-mode setup: both the optical illumination and ultrasonic detection placed on the 
same side of the imaging object6, 7, 9, 71. However, this setup imposes certain constraints on PAM’s 
performance. A long working distance is required to accommodate the sizeable piezoelectric 
detector and the optical-acoustic splitter, thus limiting the PAM’s numerical aperture and resulting 
in a poor lateral resolution76, 89. Transmission-mode PAMs have achieved finer lateral resolutions, 
but they are mainly limited to imaging ex vivo samples90, 91. Further, the complexed optical-
acoustic splitter, two prisms sandwiching a thin layer of silicon oil, is very difficult to make and 
maintain76, 89. 
To address this problem, doughnut-shaped transducers with a central opening for light passage 
have been introduced to reduce the obstruction in the optical path7, 92. But its size is still too big 
for PAM to achieve a resolution comparable to optical microscopy92. Taking another approach, 
thin-film transducers that are optically transparent offer a desirable solution. One type of these 
transducer is the optic-based ultrasonic detectors, including Fabry-Perot etalons93, 94, micro-ring 
resonators, and others95. However, they require additional optical instruments such as probe lasers 
and detectors. Further, it is difficult to integrate these optical-based detection techniques with 
conventional ultrasound excitation device for combined ultrasound/photoacoustic dual-modality 
imaging. Although transparent piezoelectric transducers with indium-tin-oxide (ITO) coated 
polyvinylidene fluoride (PVDF) film were already introduced96, 97, they demonstrated only 70% ~ 
80% transparency in the visible spectrum. Also, PVDF’s coupling coefficient (kt) is not 
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comparable with other popular piezoelectric materials. Another alternative was developed using 
the capacitive micromachined ultrasonic transducer (CMUT) technique98. This device has 
limitation on operating frequency and complex configuration that utilizes specialized micro-
electro-mechanical systems (MEMS) fabrication techniques. 
Moreover, transducers operating at the range of 30-50 MHz are favorable for PAM imaging, since 
the frequency spectrum of PA waves after propagating through tissue is dominant in this range71. 
Therefore, there is a need to find a suitable piezoelectric material to develop optically transparent 
high-frequency ultrasonic transducers for PAM application. 
Among known piezoelectric materials, lithium niobate (LiNbO3) possesses several properties ideal 
for fabricating transparent high-frequency ultrasonic transducers: It is a single-crystal material 
with excellent transparency at wavelength from 350 to 5200 nm99, good electromechanical 
coupling, a low dielectric constant, and high longitudinal sound speed, ideal for designing sensitive 
large-aperture high-frequency transducers. A brief list of the material properties for LiNbO3 can 
be found in 100. Beard et al. developed an optically transparent piezoelectric transducer with ITO 
coated LiNbO3 for ultrasonic particle manipulation101. Recently, Dangi et al. reported a promising 
LiNbO3-based transparent ultrasonic transducer operating at 14.5 MHz for PA imaging102. 
The purpose of this study is to develop a transducer for PAM applications with a high optical 
transmission (> 80 %) and a high frequency (> 30 MHz) response. The high transmission of 
LiNbO3 single-crystal substrate coated with ITO thin films on both sides is demonstrated over a 
broad range of wavelengths (450-1064 nm). PAM imaging performance of the transparent 
transducer is evaluated by imaging a carbon nanotube-based resolution target and mouse ear 
vasculatures in vivo. 
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5.2 Materials and methods 
5.2.1 Transducer design 
A Krimboltz, Leedom, and Mattaei (KLM) transducer equivalent circuit model-based modeling 
software (PiezoCAD, Sonic Concepts, Woodinville, WA, USA) was used to simulate and optimize 
the transducer design. Parylene thin-film (Parylene C, Specialty Coating Systems, Indianapolis, 
IN, USA) with an acoustic impedance of 2.5 MRayl was selected as the material for the matching 
layer because it exhibits very little absorption in the visible region and is, therefore, transparent 
and colorless. To facilitate transducer transparency, an insulating and optically transparent epoxy 
(EPO-TEK 301, Epoxy Technology, Inc., Billerica, MA, USA) with an acoustic impedance of 
3.05 MRayl was chosen as the material for backing. 
Table 5.1 Design parameters of the transparent high-frequency ultrasonic transducer 
Specifications Values 
Designed center frequency 37 MHz 
Aperture size 1 cm × 1 cm 
Thickness of piezoelectric material (LiNbO3) 100 μm 
Thickness of matching layer (parylene) 16 μm 
Thickness of backing (EPO-TEK 301) 1 mm 
 
Design parameters of the transducer are summarized in Table 5.1. The inner structure cross section 
schematic of the transducer is shown in Figure 5.1a. 
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Figure 5.1 Schematic and photo of the transparent transducer. (a) Design cross section of the transparent 
ultrasonic transducer (not to scale). (b) photograph of a fabricated transparent ultrasonic transducer. 
5.2.2 Transducer fabrication 
A 36◦ rotated Y-cut LiNbO3 (Boston Piezo-optics, Bellingham, MA) wafer with a dimension of 1 
cm × 1 cm and a thickness of 100 μm (λ/2) was acquired to make transducer operating at 37 MHz. 
Transparency of the LiNbO3 wafer was achieved by chemical surface finish technique. Both top 
and bottom sides of the LiNbO3 wafer were electroded by sputtering an ITO layer of approximately 
108 nm in total thickness. ITO was DC magnetron sputtered from a 50 mm diameter ITO target 
(In2O3/SnO2 90/10 wt %, Kurt J. Lesker Company, Jefferson Hills, PA, USA) at 20 W, 933 Pa (7 
mTorr, Argon flow ≈ 30 sccm) for 80 minutes. The deposition rate was monitored using a quartz 
crystal microbalance (QCM) with a measured rate of 0.03 nm/s (density = 7.14 g/cm3, z-ratio = 1, 
tooling = 100 %). For an accurate measure of on-sample deposition rate (LiNbO3 crystals and 
QCM are at differing heights), ITO was sputtered on a silicon substrate under similar conditions 
for 20 min and measured using a white light spectrometer (Filmetrics F40, KLA, Milpitas, CA, 
USA). The 20 min sputtered film yielded a refractive index of 1.89 and a thickness of 27 nm. 
Extrapolating these values, we estimate the thickness of the ITO film on the LiNbO3 to be 108 nm. 
A hook-up wire (Gauge 24, McMaster-Carr Supply Company, Santa Fe Springs, CA, USA) 
consisting of stranded copper wires was connected to the bottom ITO electrode on the edge of the 
LiNbO3 wafer with a small amount of conductive epoxy (E-SOLDER 3022, Von Roll Isola Inc., 
New Haven, CT, USA). A home-made brass housing with an inner opening of 15 mm in diameter 
59 
 
and a subminiature version A (SMA) connector on the side was placed concentrically with the 
LiNbO3 wafer. The other end of the stranded copper wire was connected to the SMA connector. 
Degassed EPO-TEK 301 with a total weight of 0.2 g was then poured into the brass housing. 
Therefore, the thickness of EPO-TEK 301 was controlled to be approximately 1 mm after curing. 
A small amount of E-SOLDER 3022 was applied at the four corners on the front surface of the 
LiNbO3 wafer to connect the top ITO electrode with brass housing as a ground connection. Finally, 
a 16 μm thick (λ/4) parylene thin-film (Parylene C, Specialty Coating Systems, Indianapolis, IN, 
USA) layer was vapor-deposited onto the external surface of the transducer by a parylene coater 
(PDS 2010, Specialty Coating Systems, Indianapolis, IN, USA). Photograph of the fabricated 
transducer is shown in Figure 5.1b. The transducer was not focused by either press-focusing or 
lens focusing techniques. 
5.2.3 PAM imaging 
To demonstrate applications in PAM, we conducted phantom and animal imaging with a 
reflection-mode PAM (Figure 5.2a). The laser beam from a pulsed laser (APL-4000-1064, 
Attodyne Inc., Toronto, ON, Canada) was focused onto the imaging object by an aspherical lens 
(AL2550-A, Thorlabs Inc., Newton, NJ, USA), through the transparent transducer. Excited PA 
waves were detected by the transparent transducer, which was placed in a tank of deionized water 
for acoustic coupling. Maximum amplitude projection (MAP) images were produced in post-
processing by taking the peak-to-peak amplitude of each PA A-line signal. 
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Figure 5.2 Schematic of the PAM setup and transparency measurement of the transducer. (a) Schematic of the 
reflection-mode PAM. The transparent transducer, directly in the optical path, is placed on the top of the imaging 
object to acquire the excited PA waves. The imaging object was mounted on a motorized stage for raster scans; (b) 
Measurement of optical transmission through the fabricated transducer. 
5.3 Results 
5.3.1 Transducer performance evaluations 
First, we evaluated the transducer’s optical transmission efficiency. An optical parametric 
oscillator laser (NT242, EKSPLA, Vilnius, Lithuania) provided the laser beams at a broad 
spectrum, and the ratio of the laser light transmitted through the transducer was measured with a 
laser power meter (Vega, Ophir Optronics Solutions Ltd., Jerusalem, Israel). It can be seen that 
our transducer has a transmission efficiency greater than 80% in the 450 nm to 1064 nm range 
(Figure 5.2b). 
Electrical impedance of the transducer was measured by an impedance analyzer (HP 4294A, 
Agilent Technologies, Santa Clara, CA, USA). Electrical impedance and phase angle of the 
transducer as a function of frequency were measured and shown in Figure 5.3b. The resonance 
frequency (fr) and anti-resonance frequency (fa) of the transducer were measured to be 33.9 and 
40.3 MHz, respectively. According to the IEEE standard on piezoelectricity103, the effective 
electromechanical coupling coefficient (keff) of the transducer was calculated to be 0.54. It was 
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observed that the measured results are very close to the PiezoCAD simulation results (fr = 31.0 
MHz, fa = 37.8 MHz, and keff = 0.57) as shown in Figure 5.3a. The electrical impedance of the 
transducer was measured in the range of 161 to 258 Ω around the resonance frequency of the 
transducer, while the PiezoCAD simulation shown 7 to 22 Ω. 
 
Figure 5.3 Data of the transducer impedance. (a) PiezoCAD simulated and (b) measured electrical impedance 
(blue) and phase angle (red) of a transparent transducer. 
Pulse-echo response of the transducer was measured and analyzed by a pulse-echo method 
described in104: The transducer was mounted on a holder and immersed in a tank filled with 
deionized water. An X-cut quartz plate was placed about 5 mm away from the transducer as a 
reflector. The transducer was excited by a pulser-receiver (Panametrics 5900PR, Olympus NDT 
Inc., Waltham, MA, USA) with 1 μJ energy per pulse, 200 Hz pulse repetition rate, and 50 Ω 
damping factor. The received pulse-echo response and its computed frequency spectrum are shown 
in Figure 5.4b. The center frequency of the transducer was calculated to be 36.9 MHz, and the -6 
dB bandwidth was 33.9%. Peak-to-peak received voltage (Vp-p) of the unamplified pulse-echo 
signal was about 0.45 V, indicating the transducer has quite high sensitivity. The measured pulse-
echo results are in good agreement with the PiezoCAD simulation Figure 5.4a. 
62 
 
 
Figure 5.4 Data of the transducer’s impulse response. (a) PiezoCAD simulated and (b) measured pulse-echo 
response waveform (blue) and its frequency spectrum (red) of a transparent transducer. 
5.3.2 PAM imaging 
Figure 5.5a shows the PAM image of the resolution target, carbon-nanotube patterns grown on a 
polydimethylsiloxane substrate. The smallest pattern, periodic lines of 10 μm width, 100 μm long, 
and 40 μm pitch were clearly resolved. The laser pulse energy irradiated on the target was 
measured to be ~200 nJ, resulting a signal-to-noise ratio of ~41.5. Further, we demonstrated the 
transparent transducer’s in vivo imaging capability by imaging the mouse ear at the optical 
wavelength of 532 nm. At this wavelength, the hemoglobin in red blood cells (RBCs) is the 
primary absorber in tissue, thus enabling imaging the vascular anatomy. The laboratory animal 
protocols were approved by the Institutional Animal Care and Use Committee of California 
Institute of Technology. Figure 5.4b shows the MAP image of a 1 × 0.8 mm2 area of the mouse 
ear. It can be seen that vessels of a diameter as small as 30 µm were clearly imaged. 
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Figure 5.5 Results of the transparent-transducer–based PAM imaging. (a) MAP image of the carbon-nanotube 
pattern. (b) MAP image, averaged over 16 times, of an area in the mouse ear showing the vasculature by exciting the 
hemoglobin in RBCs. 
5.4 Discussion 
In this work, a thin-film optically transparent high-frequency ultrasonic transducer using ITO 
coated LiNbO3 single-crystal was developed for PAM application. The fabricated transducer 
exhibited an effective electromechanical coupling coefficient keff of 0.54, a center frequency of 
36.9 MHz, a –6 dB bandwidth of 33.9 %, a high sensitivity of 0.45 V peak-to-peak received voltage 
(Vp-p), as well as an excellent transparency of up to 90 % in the visible range. Imaging capability 
of the transducer for PAM was also demonstrated by successfully imaging a resolution target and 
mouse ear vasculature in vivo, with the laser beam transmitting directly through the transducer. 
These results will inspire further development of high-frequency ultrasonic transducers in 
transparent form, which will enable PAM with finer resolution. Moreover, the size of the 
transducer can be further reduced, making it possessing an enormous potential for developing 
wearable or hand-held PAM devices. 
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Chapter 6: Summary and outlook 
In this dissertation, we have developed new technologies in the field of high-speed PAM. We 
applied these new technologies to translational medicine and brain functional studies, including 
CTC detection and therapy, and imaging cerebral hemodynamics in response to brief somatic 
stimulations. 
In Chapter 2, we advanced previous PAM to high-speed dual-wavelength PA flow cytography for 
the application of CTC imaging. A concurrent on-demand laser therapy device was also developed 
to photothermally lyse the CTC in pinpoint manner immediately upon CTC detection. This 
technology is readily translatable to clinics for better cancer diagnosis, therapy efficacy 
assessment, and inhibiting metastasis. 
In Chapter 3, we implement a novel wavelength conversion technique to address the limitation of 
detection sensitivity in Chapter 2. SRS was implemented to convert the pump laser to the 
wavelength of 658 nm. This wavelength choice resulted in an order of magnitude improvement in 
CNR, which facilitated reliable CTC imaging. 
In Chapter 4, we further extended the SRS wavelength conversion technique to the field of high-
speed functional imaging. A dual-wavelength high-speed functional PAM was developed for the 
studies of mouse brain hemodynamics. We successfully imaging transient micro-vascular 
hemodynamic changes in response to brief somatic stimulations. This technology has great 
promise for studies of brain functions and vascular environment. 
In Chapter 5, we explored a new ultrasonic transducer technique in an effort to extend the fPAM 
in Chapter 4 to studies of awake animals. We sought to miniaturize the detection device by 
developing a thin-film optically transparent piezoelectric transducer. An ITO coated LiNbO3 
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ultrasonic transducer was developed and its application in PAM was demonstrated with phantom 
and animal imaging. 
There are potentially broader applications for this dissertation work with certain technological 
advancements. The Raman laser in Chapter 3 and Chapter 4 has a relatively large pulse energy 
fluctuation compared to commercial lasers. The natural solution is to implement a cooling device 
on the Raman crystal KGW to enable a stable thermal environment. A more stable laser can 
facilitate more reliable and accurate measurement of the biometric parameters. 
The transparent transducer in Chapter 5 has a low detection sensitivity compared to commercial 
transducers. A potential solution is to find better materials for the matching layer and the electrode, 
as both the parylene and the ITO electrode do not match the acoustic impedance of the LiNbO3. 
The next step for fPAM is to integrate it to a wearable version for longitudinal studies on free-
moving animals. To achieve that, both the optical scanning and ultrasonic detection devices need 
to be miniaturized. For the ultrasonic detection part, we explored a thin-film piezoelectric 
transducer, whose PAM application was demonstrated in Section 5.3. Other approaches include 
optical-based ultrasound detection of the PA wave using technologies such as integrated 
interferometer. For the optical scanning part, technologies used in laser-scanning confocally 
microscopy can be readily translated to wearable PAM. Other approaches include wavefront-
engineering–based optical focusing. 
The wavelength conversion capability of the Raman laser can also enable more applications in 
multi-wavelength imaging. By simultaneously employing more Stokes lines and employing pump 
lasers of different wavelengths, it can be applied to work with more endogenous and exogenous 
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contrast mechanisms, such as lipid in the near infrared region for nerve imaging, genetically 
encoded ion indicators, like GCaMP, for functional imaging. 
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